Skip to main content
MedPathMedPath Home
Clinical Trials/EUCTR2006-001468-21-SE
EUCTR2006-001468-21-SE
Active, not recruiting
Not Applicable

Sympthomatic and prophylactic treatment of drug induced oral dryness in elderly patients with high drug consumption. - Drug induced oral dryness

Karolinska Institutet0 sitesJune 1, 2006
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsOral dryness is a common problem with serious consquences, especially among elderly individuals. The most common reason for oral dryness is drug consumption. Research has shown that an individual with more than 5 prescribed drug is at risk for oral problems. Drug consumtion is increasing among elderly, mostly due to lack in cooperation in the health care system. Oral dryness have impact on quality of life with eating difficulties and an increased rsik for dental caries.

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Oral dryness is a common problem with serious consquences, especially among elderly individuals. The most common reason for oral dryness is drug consumption. Research has shown that an individual with more than 5 prescribed drug is at risk for oral problems. Drug consumtion is increasing among elderly, mostly due to lack in cooperation in the health care system. Oral dryness have impact on quality of life with eating difficulties and an increased rsik for dental caries.
Sponsor
Karolinska Institutet
Status
Active, not recruiting
Last Updated
14 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
June 1, 2006
End Date
TBD
Last Updated
14 years ago
Study Type
Interventional clinical trial of medicinal product
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • •Swedish talking patients at least 65 years old with at least 6 medically prescribed drugs (not products free for sale) and with at least 10 natural teeth.
  • •Are the trial subjects under 18? no
  • •Number of subjects for this age range:
  • •F.1\.2 Adults (18\-64 years)
  • •F.1\.2\.1 Number of subjects for this age range
  • •F.1\.3 Elderly (\>\=65 years) yes
  • •F.1\.3\.1 Number of subjects for this age range

Exclusion Criteria

  • •Sjögrens syndrom, radiation teraphy against head/neck cancer, ongoing treatment with cytostatics, serious diseases that may undo fulfillment of participation in the study, communication difficulties in swedish.

Outcomes

Primary Outcomes

Not specified

Similar Trials

Active, not recruiting
Phase 1
Pharmaco-epidemiology of the treatment of the symptomatic pulmonary embolism among in-patients and 75 years old or more: prospective, multicentric PEAGE cohort
EUCTR2013-000315-24-FRCHU SAINT-ETIENNE1,500
Completed
Phase 3
Spontaneous Urinary Stone Passage ENabled by Drugs
ISRCTN69423238niversity of Aberdeen (UK)1,200
Active, not recruiting
Phase 1
se of drug therapy in the management of symptomatic ureteric stones in hospitalised adults: a multicentre placebo controlled randomised trial of a calcium channel blocker(nifedipine)and an alpha blocker(tamsulosin) - The SUSPEND trial - Symptomatic ureteric stone passage enabled by drugs (SUSPEND)se of drug therapy in the management of symptomatic ureteric stones in hospitalised adults: multicentre placebo controlled randomised trial of a calcium channel blocker(nifedipine) and an alpha blocker (tamsulosin).
EUCTR2010-019469-26-GBniversity of Aberdeen1,167
Completed
Phase 1
Efficacy and safety of Chinese herbal medicine (RCM-102) for treatment of seasonal allergic rhinitis (hayfever)seasonal allergic rhinitisInflammatory and Immune System - AllergiesRespiratory - Other respiratory disorders / diseasesAlternative and Complementary Medicine - Herbal remedies
ACTRN12612000209897Professor Charlie Xua104
Completed
Phase 4
Combination drug therapy for fibromyalgia paiFibromyalgiaMusculoskeletal DiseasesOther soft tissue disorders, not elsewhere classified
ISRCTN20173707Queen's University (Canada)69